Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Eriksson, Hannaa | Fereshtehnejad, Seyed-Mohammada | Falahati, Farshada | Farahmand, Bahmanb | Religa, Dorotab; c | Eriksdotter, Mariaa; c; *
Affiliations: [a] Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden | [b] Alzheimer's Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden | [c] Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden
Correspondence: [*] Correspondence to: Maria Eriksdotter, Division of Clinical Geriatrics dept Neurobiology, Care Sciences and Society, Novum, plan 5, Karolinska Institutet, 141 86 Stockholm, Sweden. Tel.: +46 8 524 845 67; Fax: +46 8 524 868 09; E-mail: [email protected].
Abstract: Background:Due to age of onset, Alzheimer’s disease (AD) is divided into early onset (EOAD) or late onset (LOAD), but emerging data also suggests that the underlying pathology may be different. Whether differences in clinical care exist is less well investigated. Objectives:To evaluate whether there are differences in demographics, diagnostic work-up, and pharmacological treatment between EOAD and LOAD. Material and Methods:Data on patients with newly diagnosed EOAD (n = 453) and LOAD (n = 4599) was obtained from the Swedish dementia registry (SveDem). Logistic regression models were used to adjust the comparisons for the baseline confounders including gender, cognitive decline, and co-morbidity. Results:The majority of EOAD and LOAD were in the mild stage of the disease when diagnosed. The majority of patients with EOAD went through an extended diagnostic work-up including more technical investigations as well as assessments by neuropsychologists and speech therapists than patients with LOAD. EOAD patients were treated with overall fewer medications but obtained treatment with cholinesterase inhibitors to a higher extent than those with LOAD, while there were no differences between the groups in antidepressant and antipsychotics use. Conclusions:There are differences between EOAD and LOAD in demographics, diagnostic work-up, and pharmacological treatment. Based on our findings, an extensive work-up should be recommended when EOAD is suspected.
Keywords: Early onset Alzheimer's disease, cholinesterase inhibitors, dementia diagnostic work-up, late-onset Alzheimer's disease, quality registry
DOI: 10.3233/JAD-132273
Journal: Journal of Alzheimer's Disease, vol. 41, no. 2, pp. 411-419, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]